DREB2E Antibody

Shipped with Ice Packs
In Stock

Description

Contextual Overview of DREB2E

DREB2E (Dehydration-Responsive Element-Binding Protein 2E) is a transcription factor in plants, notably studied in Arabidopsis thaliana (At2g38340). It belongs to the AP2/ERF family and plays a role in stress responses, including heat and drought . Unlike its homolog DREB2A, which is well-characterized in stress signaling pathways, DREB2E remains understudied, with limited functional or structural data .

Antibody Development Landscape

While antibodies targeting plant transcription factors like DREB2A exist for research purposes (e.g., polyclonal antibodies for Western blotting) , no peer-reviewed studies or commercial entities have reported the development or validation of a DREB2E-specific antibody. Key observations:

  • Plant Biology Research: Antibodies against plant proteins (e.g., DREB2A) are typically custom-made for academic studies and not commercialized .

  • Therapeutic Antibodies: Current antibody therapeutics focus on human targets (e.g., SARS-CoV-2, cancer antigens) , with no overlap with plant transcription factors.

Potential Applications and Challenges

  • Low Commercial Demand: Plant transcription factors are niche targets compared to human disease-related proteins.

  • Technical Barriers: High sequence homology among DREB2 isoforms complicates antibody specificity .

Comparative Analysis of DREB2-Related Antibodies

FeatureDREB2A AntibodyHypothetical DREB2E Antibody
Research UseWidely used in plant studies Not reported
Commercial AvailabilityCustom orders only None
Therapeutic RelevanceNoneNone

Future Directions

  • Functional Studies: Prioritize structural characterization of DREB2E to identify epitopes for antibody design.

  • Collaborative Efforts: Partnerships between academic labs and biotech firms could enable antibody development for agricultural biotechnology applications.

Product Specs

Buffer
**Preservative:** 0.03% Proclin 300
**Constituents:** 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
DREB2E antibody; ERF41 antibody; Os03g0174400 antibody; LOC_Os03g07830Dehydration-responsive element-binding protein 2E antibody; OsDREB2E antibody
Target Names
DREB2E
Uniprot No.

Target Background

Function
DREB2E Antibody targets a protein that functions as a probable transcriptional activator. This protein binds to the DNA sequence 5'-[AG]CCGAC-3', which is recognized as the cis-acting dehydration-responsive element (DRE).
Protein Families
AP2/ERF transcription factor family, ERF subfamily
Subcellular Location
Nucleus.

Q&A

What is DREB2E and why are antibodies against it important for plant stress research?

DREB2E is a member of the DREB2 (Dehydration-Responsive Element-Binding protein 2) family of transcription factors that play crucial roles in plant responses to abiotic stresses, particularly drought, heat, and salinity. Like its better-characterized relative DREB2A, DREB2E is likely involved in transcriptional regulation of stress-responsive genes .

Antibodies against DREB2E are essential tools for studying its expression patterns, protein-protein interactions, post-translational modifications, and subcellular localization during stress conditions. Similar to studies with DREB2A, these antibodies allow researchers to investigate how DREB2E may interact with other proteins (such as potential E3 ligases) that could regulate its abundance and activity . Understanding these mechanisms is fundamental to developing crops with enhanced stress tolerance.

How can researchers verify the specificity of a DREB2E antibody?

Verifying antibody specificity for DREB2E requires multiple validation approaches:

  • Western blot analysis with positive and negative controls:

    • Use recombinant DREB2E protein as a positive control

    • Include protein extracts from knockout/knockdown plants as negative controls

    • Test cross-reactivity with other DREB2 family members (especially DREB2A) using purified proteins

  • Immunoprecipitation followed by mass spectrometry:

    • Confirm that immunoprecipitated proteins include DREB2E

    • Assess whether related proteins are also captured

  • Immunohistochemistry with knockout controls:

    • Compare staining patterns between wildtype and DREB2E-deficient plant tissues

  • Peptide competition assay:

    • Pre-incubate antibody with DREB2E-specific peptides before immunodetection

    • Observe if this blocks binding to demonstrate epitope specificity

These approaches help ensure that experimental results truly reflect DREB2E biology rather than antibody cross-reactivity with related DREB2 family members.

What are the recommended fixation and extraction methods when using DREB2E antibodies?

For optimal results with DREB2E antibodies in plant tissues:

Protein Extraction for Western Blotting:

  • Use a buffer containing 50mM Tris-HCl (pH 7.5), 150mM NaCl, 1% Triton X-100, 0.5% sodium deoxycholate, and protease inhibitor cocktail

  • Include phosphatase inhibitors if studying phosphorylation states

  • Add 25mM MG132 (proteasome inhibitor) to prevent degradation, as DREB2 family proteins are often targeted for ubiquitin-mediated proteolysis

  • Extract proteins at 4°C to minimize degradation

Fixation for Immunohistochemistry:

  • 4% paraformaldehyde for 2-4 hours provides good structural preservation

  • For detecting nuclear localization, include an antigen retrieval step (similar to protocols used for DREB2A)

  • When examining interactions with potential E3 ligases (similar to DRIP1/DRIP2 for DREB2A), consider using protein crosslinking approaches

How can researchers use DREB2E antibodies to study protein degradation mechanisms?

Based on knowledge from DREB2A research, DREB2E is likely regulated through the ubiquitin-proteasome system. Researchers can use DREB2E antibodies to:

  • Monitor protein half-life:

    • Perform cycloheximide chase assays to track DREB2E degradation rates under different stress conditions

    • Compare degradation kinetics between wildtype plants and those with mutations in potential E3 ligases

  • Identify ubiquitination sites:

    • Immunoprecipitate DREB2E using specific antibodies

    • Analyze ubiquitinated forms using mass spectrometry

    • Compare results with the known regulatory mechanisms of DREB2A

  • Detect E3 ligase interactions:

    • Use co-immunoprecipitation with DREB2E antibodies followed by mass spectrometry to identify interacting E3 ligases (similar to how DRIP1 and DRIP2 were found to interact with DREB2A)

    • Confirm interactions using in vitro pull-down assays with purified proteins

  • Visualize subcellular dynamics:

    • Employ immunofluorescence with DREB2E antibodies to track protein localization under stress conditions

    • Compare with known nuclear localization patterns of DREB2A

This methodological approach can reveal how DREB2E abundance is regulated in response to environmental stresses, potentially uncovering mechanisms similar to the DRIP1/DRIP2-mediated regulation of DREB2A .

What are the challenges in developing highly specific antibodies that distinguish between DREB2E and other DREB2 family members?

Developing antibodies that specifically recognize DREB2E while avoiding cross-reactivity with other DREB2 family proteins presents several challenges:

  • Sequence homology: DREB2 family members share significant sequence similarity, particularly in the DNA-binding domain. Based on research with DREB2A, this domain is often involved in protein-protein interactions, making it challenging to develop antibodies that target this region without cross-reactivity .

  • Epitope selection strategies:

    • Target unique regions in the C-terminal domain, which tends to have greater sequence divergence

    • Consider using peptide antigens from regions that are unique to DREB2E

    • Avoid the conserved AP2/ERF domain that defines the DREB family

  • Cross-adsorption techniques:

    • Pre-adsorb antibodies with recombinant proteins of related DREB2 family members

    • Use affinity purification with DREB2E-specific peptides

  • Validation requirements:

    • Test against knockout/knockdown lines for multiple DREB family members

    • Perform side-by-side comparison with antibodies against other DREB2 proteins

    • Validate using orthogonal methods (e.g., mass spectrometry of immunoprecipitated proteins)

DREB2 Family MemberKey Distinguishing Regions for Antibody DevelopmentPotential Cross-Reactivity Concerns
DREB2AN-terminal region containing NRD domainHigh sequence similarity in DNA-binding domain
DREB2EC-terminal variable regionPotential conformational epitopes shared with other family members
Other DREB2 proteinsUnique insertion/deletion regionsPost-translational modifications may alter epitope accessibility

How can computational approaches be applied to DREB2E antibody design and epitope prediction?

Recent advances in computational protein design can be leveraged for developing more specific DREB2E antibodies:

  • RFdiffusion network approaches:

    • Similar to the methods described in recent antibody design research, computational tools can be used to design antibodies with atomic-level precision targeting specific DREB2E epitopes

    • This approach allows for rational design of antibody variable domains (VHH or scFv) that selectively bind to DREB2E but not other DREB2 family members

  • Epitope prediction algorithms:

    • Analyze the DREB2E sequence to identify regions with high antigenicity and surface accessibility

    • Use structural modeling to predict epitopes that are unique to DREB2E compared to other DREB2 proteins

    • Apply machine learning approaches to refine epitope predictions based on known antibody-antigen interactions

  • In silico screening:

    • Generate virtual libraries of antibody candidates

    • Perform computational docking to predict binding affinity and specificity

    • Select candidates with optimal predicted properties for experimental validation

  • Affinity maturation simulation:

    • Model potential mutations in the complementarity-determining regions (CDRs)

    • Predict how these mutations affect binding affinity and specificity

    • Design directed evolution strategies based on computational predictions

This computational-experimental hybrid approach can significantly reduce the time and resources needed to develop highly specific DREB2E antibodies while improving their performance in research applications.

What controls are essential when using DREB2E antibodies in stress response experiments?

When designing experiments to study DREB2E in stress responses, several critical controls should be included:

  • Genetic controls:

    • DREB2E knockout/knockdown lines to confirm antibody specificity

    • DREB2A knockout lines to rule out cross-reactivity with this closely related protein

    • Overexpression lines to validate antibody detection under varying expression levels

  • Treatment controls:

    • Time-course sampling to capture dynamic changes in DREB2E levels

    • Multiple stress conditions (drought, heat, salt) to compare response patterns

    • Recovery periods to assess protein level normalization

  • Technical controls for western blotting:

    • Pre-immune serum as a negative control

    • Loading controls (housekeeping proteins) appropriate for stress conditions

    • Proteasome inhibitors (e.g., MG132) in parallel samples to assess degradation rates

  • Controls for protein-protein interaction studies:

    • Pull-down with pre-immune serum or unrelated antibodies

    • Competition with excess antigen peptide

    • Inclusion of known interacting partners (based on DREB2A interactions with DRIP1/DRIP2)

These comprehensive controls help distinguish between specific DREB2E responses and general stress effects or technical artifacts.

How can DREB2E antibodies be used to investigate post-translational modifications during stress responses?

DREB2E, like other DREB2 family members, likely undergoes various post-translational modifications (PTMs) that regulate its activity, stability, and interactions. Antibodies can be powerful tools for studying these modifications:

  • Phosphorylation analysis:

    • Use general DREB2E antibodies for immunoprecipitation followed by phospho-specific antibodies or mass spectrometry

    • Compare phosphorylation patterns under different stress conditions

    • Correlate phosphorylation with protein stability and transcriptional activity

  • Ubiquitination detection:

    • Immunoprecipitate DREB2E and probe with anti-ubiquitin antibodies

    • Compare ubiquitination patterns in plants with mutations in E3 ligases (similar to the DRIP1/DRIP2 system for DREB2A)

    • Use proteasome inhibitors to accumulate ubiquitinated forms for easier detection

  • SUMOylation and other modifications:

    • Co-immunoprecipitation followed by western blotting with SUMO-specific antibodies

    • Mass spectrometry analysis of immunoprecipitated DREB2E to identify various modifications

  • Correlation with function:

    • Compare PTM patterns with DNA binding activity using chromatin immunoprecipitation (ChIP)

    • Assess how PTMs affect protein-protein interactions using in vitro binding assays

    • Determine localization changes associated with specific modifications

Post-translational ModificationDetection MethodFunctional Significance
PhosphorylationPhospho-specific antibodies or mass spectrometry after IPMay regulate DNA binding activity and protein stability
UbiquitinationAnti-ubiquitin western blot after IP with DREB2E antibodyTargets protein for proteasomal degradation, similar to DREB2A
SUMOylationSUMO-specific antibodies after IPMay alter subcellular localization or protein interactions
Other PTMsMass spectrometry after IPCould affect various aspects of protein function

What are common issues with DREB2E antibody specificity and how can researchers address them?

Researchers often encounter several challenges when working with DREB2E antibodies:

  • Cross-reactivity with other DREB2 family members:

    • Solution: Pre-adsorb antibodies with recombinant proteins of related DREB2 family members

    • Validate results using DREB2E knockout plants alongside wildtype samples

    • Consider using epitope-tagged DREB2E in transgenic plants when possible

  • Weak signal detection:

    • Solution: Optimize extraction buffers to include proteasome inhibitors like MG132, as DREB2 proteins are often rapidly degraded

    • Concentrate samples using immunoprecipitation before western blotting

    • Use signal enhancement systems optimized for plant proteins

  • Variable results across stress treatments:

    • Solution: Carefully standardize stress application protocols

    • Include time-course sampling to capture transient changes in protein levels

    • Compare results with transcript levels to distinguish between transcriptional and post-transcriptional regulation

  • Background in immunolocalization:

    • Solution: Increase blocking stringency (5% BSA or milk protein)

    • Include competing peptides in negative controls

    • Optimize fixation and antigen retrieval protocols specifically for plant transcription factors

These troubleshooting approaches can significantly improve the reliability and reproducibility of DREB2E antibody-based experiments.

How can researchers use DREB2E antibodies to study protein-protein interactions in stress signaling pathways?

DREB2E antibodies are valuable tools for investigating protein-protein interactions within stress signaling networks:

  • Co-immunoprecipitation (Co-IP) approaches:

    • Use DREB2E antibodies to pull down protein complexes from plant tissues under various stress conditions

    • Analyze co-precipitated proteins by mass spectrometry to identify novel interaction partners

    • Compare results with known DREB2A interactors like DRIP1 and DRIP2

  • Proximity labeling techniques:

    • Create fusion proteins with BioID or APEX2 proximity labeling enzymes

    • Use DREB2E antibodies to confirm proper expression and localization of fusion proteins

    • Identify proteins in close proximity to DREB2E during stress responses

  • In vitro validation methods:

    • Express recombinant DREB2E and candidate interacting proteins

    • Perform pull-down assays using DREB2E antibodies to confirm direct interactions

    • Map interaction domains through truncation analyses, similar to the approaches used for DREB2A-DRIP interactions

  • Functional validation:

    • Use yeast two-hybrid or split-luciferase assays to confirm interactions identified by Co-IP

    • Perform mutagenesis of key residues to disrupt specific interactions

    • Correlate interaction patterns with transcriptional activity using reporter gene assays

These approaches can reveal how DREB2E function is regulated through protein-protein interactions and how these interactions may change during different stress conditions.

How might computational antibody design approaches improve DREB2E-specific antibody development?

Recent advances in computational antibody design offer promising approaches to develop next-generation DREB2E antibodies:

  • De novo antibody design using RFdiffusion:

    • Apply fine-tuned RFdiffusion networks to design antibody variable domains with atomic-level precision targeting specific DREB2E epitopes

    • Design antibodies that can distinguish between closely related DREB2 family members

    • Create antibodies that recognize specific post-translationally modified forms of DREB2E

  • Structure-based epitope targeting:

    • Use structural models of DREB2E to identify unique surface regions

    • Design antibodies that specifically recognize these regions while avoiding conserved domains

    • Create antibodies that can distinguish between different conformational states

  • Affinity and specificity optimization:

    • Use computational affinity maturation to improve binding properties

    • Screen virtual libraries to identify optimal candidates before experimental validation

    • Design antibodies with controlled cross-reactivity profiles for comparative studies

  • Specialized functional antibodies:

    • Design antibodies that specifically inhibit or enhance DREB2E interactions with other proteins

    • Create antibodies that recognize specific DNA-bound conformations

    • Develop reagents that can distinguish between active and inactive forms

These computational approaches could significantly accelerate the development of highly specific research reagents for studying DREB2E function.

What methodological advances are needed to better study DREB2E using antibody-based approaches?

Several methodological advances would enhance DREB2E research using antibodies:

  • Single-cell resolution techniques:

    • Develop immunohistochemistry protocols optimized for plant tissues that maintain cellular architecture

    • Adapt single-cell western blotting for plant samples to study cell-specific DREB2E expression

    • Combine with laser capture microdissection to analyze tissue-specific protein complexes

  • Live-cell imaging approaches:

    • Develop cell-permeable antibody fragments or nanobodies for tracking DREB2E in living plant cells

    • Optimize proximity labeling approaches for plant transcription factors

    • Create split-protein complementation assays specifically calibrated for nuclear proteins

  • High-throughput interaction mapping:

    • Adapt antibody-based protein array technologies for plant transcription factors

    • Develop multiplexed co-immunoprecipitation approaches to simultaneously analyze multiple DREB2 family members

    • Create microfluidic platforms for automated immunoprecipitation from small samples

  • Quantitative analyses:

    • Standardize absolute quantification methods for DREB2E using recombinant protein standards

    • Develop multiplexed western blotting to simultaneously measure multiple post-translational modifications

    • Create internal reference standards for more accurate comparison across experiments

These methodological advances would address current limitations in studying plant transcription factors like DREB2E and enable more sophisticated analyses of their roles in stress responses.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.